Skip to main content
Clinical Trials/NL-OMON50648
NL-OMON50648
Completed
Not Applicable

STEPWISE treatment of uncontrolled HyperTensioN in primary care: a cluster randomised trial. - STEPWISE HT

Julius Centrum0 sites240 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Julius Centrum
Enrollment
240
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Julius Centrum

Eligibility Criteria

Inclusion Criteria

  • Patients aged \> 18 years and \< 80 years with an office blood pressure \> 140/90
  • mmHg, on at least two blood pressure measurements per visit and on at least two
  • occasions in the last year despite prescription of three or more blood pressure
  • lowering drugs of different classes at adequate dosage, with for each
  • antihypertensive drug at least 1 prescription of 3 months. During the inclusion
  • consultation, the office blood pressure should be \> 140/90 mmHg (measured
  • according to the guideline on \*standardized office blood pressure measurement
  • based on the NHG CVRM guideline).

Exclusion Criteria

  • \- A short life expectancy (\< 6 months) as judged by the GP.
  • \- Inability to understand or conform to the stepwise protocol.
  • \- Unwillingness to provide a written informed consent.
  • \- In case of suspicion of a hypertensive crisis (systolic blood pressure \* 200
  • mmHg and/or diastolic blood pressure \* 120 mmHg) the patient is referred for
  • further evaluation. If a hypertensive crisis is excluded, the patient can be
  • included in the study.
  • \- Atrial fibrillation (because of difficulties to interpret 24 hour BP
  • measurements)
  • \- Pregnancy or breast feeding.

Outcomes

Primary Outcomes

Not specified

Similar Trials